Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
SlideShare a Scribd company logo
Dr. SHAFI ULLAH KHAN
Resident Internal Medicine
MAW LRH Peshawar
Learning Objective
Diagnostic Criteria
Diagnostic Criteria
Recurrent Headache 4 – 72 Hrs.
5 episodes
Normal Physical Examination
1 Of Following
Nausea,Vomiting,Photophobia
Phonophobia
2 Of The Following
Unilateral, Throbbing, Aggrevated
by movements, Moderate to severe
intensity
Migraine
Clinical Features Of Migraine
Nausea 87 % Vertigo 33%
Photophobia 82% Photopsia 26%
Dizziness 72% Diarrhea 16%
Scalp Tenderness 65% Fortification Spectra 10%
Vomiting 56% Syncope 10%
Visual Aura 36% Seizures 4%
Paresthesias 33% Confusion 4%
Pyramid Of Clinical Presentation
5 Phases Of Migraine
Bird Eye View
Features Of Migraine Aura
• Precedes or
accompany
• Develops
Over 5 – 20
min
• Lasts Less
than 60 Min
• Visual
Symptoms
common
• Scotoma
• Tunnel vision
• hemianopia
• Complete
Blindness
• Auditory ,
motor,
sensory also
possible.
Migraine
Visual Symptoms
(Dazzle camouflage WW2/ Fortification Spectrum)
Visual Symptoms
Migraine
Migraine
Migraine
Classification of Migraine
• Migraine With Out Aura
• Probable Migraine With Out
Aura
• Migraine With Aura
• Probable Migraine With
Aura
• Chronic Migraine
• Analgesic Overuse Migraine
• Childhood Periodic
Syndrome (May Not attributed to
Migraine)
• Complications Of Migraine
• Miscellaneous ( Not fitting
above)
Variants Of Migraine
Childhood
Periodic
Syndrome
Hemiplegic
Migraine
Ophthalmople-
-gic Migraine
Retinal
Migraine
Status
Migrainosus
Late Life
Accompanime
nt Of Migraine
Basilar
Migraine
Pathophysiology
Vascular Theory Neurovascular theory
Pathophysiology
Cortical Spreading
Depression
Oligemia
Trigeminovascular
System
Metalloproteinase Hypoxia
Pathophysiology
Vasoactive Substances And Neurotransmitters
• Migraine center
Brainstem Activation
• Cutaneous Allodynia
Pathophysiology
Dopamine Pathway
• Magnesium Deficiency
Endothelial Dysfunction
• Serotonin Pathways
Pathophysiology
Trigeminal
Neuron
CGRP
Trigemino
Cervical
Complex
• Periaqueductal Grey Matter
• Pons( Locus ceruleus)
• RVM medulla
Thalamus
1st order Neuron
2nd order neuron
3rd order neuron
Trigemino Vascular Theory
Lt Side Spontaneous
Migraine
Rt. Side spontaneous
Migraine
• Lateralization to the side of the pain
• DorsoLateral Pons ( Nor adrenergic Locus Ceruleus)
Familial Hemiplegic Migraine
Migraine Disability Assessment Score
(MIDAS)
Work
• No of days missed completely_____
• Days where efficiency reduced to half or more___
Household Activity
• Days missed completely____
• Days productivity reduced to half or more___
Social
• No of days social gatherings, leisure activities missed.
Migration Disability Assessment Score
Grade 4
>20 days
Grade 3
10-20 days
Grade 2
6-10 days
Grade 1
0-5 days
Migraine Disability Assessment Score
(Continued)
ID-CM Screening Tool
12 Item screening tool for chronic Migraine (15 days or more in a month)
• 82% sensitive.
• 87 % specific.
• 90% PPV.
Pain moderate or severe ( Frequency)
Clinical features e.g Nausea, vomiting, photophobia ( Frequency)
• How often they worry about missing school, social activity or work.
Cluster
Headache
Cerebral
Aneurysm
Chronic
Paroxysmal
hemicrania
s
Herpes
Simplex
Encephalitis
Meningitis
Intra Cranial
hemorrhage
Dissection
Syndrome
Tolosa-Hunt
Syndrome
Temporal /
G.C Arteritis
Muscle
Contraction
Tension
Headache
Meet Dr. Sheldon Cooper
He doesn’t like change
Triggers
Excess of sleep Change In
Weather
Exposure to
Bright
Fluorescent
Light
Insomnia
Triggers
Noise
>50
decibels
Noise
Barometric
Pressure
Changes
Alcohol
Triggers
Vasodilators Contraceptive Pills Smoking
Triggers
Strong Odor Cold Stimulus Head Trauma
Triggers
Motion Sickness Fasting / skipped Meals Lack Of exercise
Triggers
Caffeine MSG
Triggers
Tyramine Citrus Fruits
Processed Foods /
Meat
Triggers
Chocolate Heavily Yeasted Bread Nuts
Triggers
Pickled Food Vinegar Red wine
Migraine Diary
?
Bravelet!
Awareness
Jessica Lynch
Migraine
Non Pharmacological Measures
BiofeedBack
Cognitive
Behavioral
Therapy
Relaxation
Therapy
Non Pharmacological Measures
• Implant near occipital nerve
• Pulse generator gluteal muscles,
collar bone.
• Sine 1977ONS
• Age>18 Interruption to hyper
exaggerated response to normal
sensory stimuli.
• Migraine with aura
• Metals, Stimulators, Pacemakers,
Epilepsy Hx.
TMS
Complimentary Alternating Medicine
Butter Bur Herb (Petasites Hybridus)
Also called battle dock, bog rhubarb, bogshorn, capdockin
Level A Recommendation From American Headache
Association / American Association Of Neurology AHS/AAN.
Pyrrolizodine Alkaloid(Hepatotoxic) Free (PA Free) Brands
approved by FDA for Migraine management.
CAM (Continued…..)
Feverfew (Santa Maria/ Tenecitum
Parthenium)
Feverfew
>Active ingredient
-Parthenolide
>Dosage
-50-100 mg
extract daily.
CAM (continued…..)
-Riboflavin
-400mg
Magnesium
(Membrane stabilizer)
CoQ-10
Antioxidant
Melatonin 8 week therapy 2mg 1 hr. bedtime
MIDAS reduced by 50%
CAM Continued…..
Trans cranial Electric Nerve Stimulation TENS
CAM continued…..
FDA approved
(2014)
20 minutes a day
Self Adhesive
Electrode in
center
Stimulates
Trigeminal Nerve
TENS Electrodes
with pulse
generator
Contraindication
Pacemakers
Epilepsy
Bath /Shower
Body Work ( CAM ….)
CST Acupressure Bowen Technique
Body Work (CAM…)
Chiropractic A Day At SPA
Ayurveda
LomiLomi
(salmon,
kahuna, nui)
Hawaiian
Massage
Osteopathy
Body Work ( CAM)
Chiropractic Osteopathy Napratherapy
Body Work ( CAM….)
Physiotherapy Rolfing Structural Integration Shiatsu
Japanese Massage
Body Work ( CAM…)
Watsu
Body Work ( CAM….)
Yoga Pilates Tui Na
• When To Treat Aggressively?
Smoking OCPs Cardiovascular
Go Green Mother Nature!
?
AAN
AAN
5 Don’ts
Performing Neuroimaging in Stable
headaches fulfilling Migraine
Criteria.
Performing CT When MRI available
Except Emergency
Recommending surgical
Deactivation Of Migraine Trigger
Points
5 Don’ts
Prescribing Opioids and
Butalbitals as fine line
treatment for recurrent
migraine headaches.
Recommending prolonged and
frequent use of OTC pain meds
When To Do Neuroimaging?
Pattern
Change
First Or
Worst
Age>50
Abnormal
Examination
Epilepsy
Posterior
located
Headaches
New Daily,
persistent
Fever
Worsening
Symptoms
Immunocompr
-omised
Treatment Of Migraine
5 Steps
Abortive Therapy
Abortive Therapy
Earlier The Better (15 Minutes Of Onset)
Rebound Headache
Use >2-3 days
1)Dopamine Antagonists
2)IV Metoclopramide 10=20=40
3)Ketarolac=Meperidine=Sumatr
-iptan
STIP?
I Live Away From Hospital?
Self Medication FDA
Approved
Caffeine
Acetami
nophen
Aspirin
When To Do Prophylaxis?
Frequency> 2/ Month
MIDAS II or More
Ineffective Symptoms Relief
Duration > 24 Hours
Failed Abortive/ Overuse
Migraine Variants
Goals Of Prophylaxis
Frequency
Duration
Severity
Responsi
veness
To Attack
Disability
What To Do At Casualty
Combination Therapy
5HT1B/1D Agonists, NSAIDs Dopamine Receptor Agonists
No Opioids Unless Thoroughly Assessed
Migraine Time, Ineffective Cool Compresses over pain site
Minimize Sensory Stimuli
Visual Auditory
When To Admit?
• Nausea, Vomiting
• Dehydration
• Status Migranosus
• Refractory Migraine
• Medication Overuse
• (Ergot alkaloids, Opioids, Analgesics)
Which One Better?
Clinic
<
>
OPD Casualty
Clinic
Private Setup
Private insurance
Medicare / Medicaid
ER
Casualty
prophylaxis
Major Prophylaxis Measures
5HT2 Antagonist
Methysergide
Voltage Gated Ca+2 Channel
Blockers
Gabaergic Inhibition
(Valproic Acid)
Central Neurotransmitter
Modulators
(Beta Blocker, TCA )
Major Prophylaxis Measures
Antiepileptic
Antihypertensive
Anti Depressants
When To Consider prophylaxis failure
Botox ®
Only FDA Approved For Chronic Migraine
1)Failure of 3
Preventive Meds.
2)Scalp & Temple
3) Every 2-3 Months
4)Up to 6 months at
least
Status Migrainosus
>72 hours
Admit / Inpatient care
Valproate +
Dihydroergotamine
?
Did You Know?
Serena Williams
Menstrual Migraines
"I'd never heard of
[menstrual migraines]
before, All this time, I
thought it was a
regular migraine.“
Serena Williams
Menstrual Migraine
Abortive Same As Non Menstrual
Preventive: Long Acting Triptan
(Fravitriptan)
Hormonal Therapy
Perimenstrual 0.5mg oral Estradiol
1mg Transdermal Patch. 24/4 > 21/7
Corrugator Muscle Resection
Future Novelty Treatment
Tonabersat ( Gap Junction Modulator)
Tonabersat
>Between Neurons &
Satellite glial cells .
>Trigeminal Ganglion.
>Inhibit CSD.
Future Novelty Meds
TRPV1 – Capsaicin Receptor
Transient Receptor
Potential Vanilloid Type1
Antagonists.
Future Novelty Drugs
Prostaglandin E 4 Receptor Antagonist.
Future Novelty Medicine
Serotonin 5 HT 1 F receptor Agonists
Future Novelty Drugs
Nitric Oxide Synthase Inhibitors
NMDA Receptor Antagonist
Need More? Call Them
1-888-INFO-FDA
1-888-463-6332
Did You Know?
Every 3rd case Of vertigo is actually migraine and wrongly labeled as vertigo.
• Migraine with neurological symptoms and vertigo and hemiparesis is
called Acephalgic Migraine.
Triptans Don’t work in Aura and should be used when migraine starts.
• Long Acting Triptans are best choice in Menstrual Migraine . Fravitriptan.
Did you Know?
27 Billion Euros are spent per annum in Europe
• Good Headache histories are taken not given.
• Migraines can not be cured. Only managed. Inherited tendency.
19.6 Billion USD are spent per year in USA.
In the UK, there are an estimated 190,000 migraine attacks every day
• Migraine is amongst the three most prevalent health conditions
worldwide, along with anemia and hearing loss.
Did you Know?
An estimated 25 million days are lost from work or school every year
because of migraine
• one-third of all patients consult because of headache – more than for any
other complaint
Depression is three times more common in people with migraine or severe
headaches than in healthy individuals
• Migraine remains undiagnosed and undertreated in at least 50% of
patients, and less than 50% of migraine patients consult a physician.
Famous Celebrities With Migraine?
Famous Celebrities With Migraine
Phoebe Buffay (Lisa
Kurdow) FRIENDS
Janet Jackson Kareem Abdul Jabbar
Celebrities With Migraine?
Celebrities With Migraine
Take Home Message
To Whom It May Concern
Acknowledgements
Acknowledgements
Reference
• Harrison Principles of internal medicine 19th edition.
• Up-to-date Lippincott Williams and Wilkins
• Medscape
• Mayo clinic Guidelines
• NIH / NHS
• Oxford Textbook Of Internal Medicine
• International Headache association Guidelines
• JAMA , BJM, AAN, FDA.
Imitrex (sumatriptan succinate) tablets. Prescribing Information. GlaxoSmithKline.
February 2010. [Full Text].
Imitrex (sumatriptan) Nasal Spray. Prescribing Information. GlaxoSmithKline. February
2010. [Full Text].
Leonardi M, Mathers C. Global burden of migraine in the Year 2000: summary of
methods and data sources. World Health Organization. Available at
http://www.who.int/healthinfo/statistics/bod_migraine.pdf. Accessed March 27, 2013.
Lowry F. Chronic Migraine Responds to OnabotulinumtoxinA. Medscape Medical
News. Available at http://www.medscape.com/viewarticle/825002. Accessed May 19,
2014.
Minson CT, Green DJ. Measures of vascular reactivity: prognostic crystal ball or
Pandora's box?. J Appl Physiol. Aug 2008;105(2):398-9. [Medline].
[Guideline] Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E.
Evidence-based guideline update: pharmacologic treatment for episodic migraine
prevention in adults: report of the Quality Standards Subcommittee of the American
Academy of Neurology and the American Headache Society. Neurology. Apr 24
2012;78(17):1337-45. [Medline]. [Full Text].
Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, et al.
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind,
randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. Jun
2010;50(6):921-36. [Medline].
Jeffrey S. FDA Approves First Device to Prevent Migraine. Medscape Medical News. Available
at http://www.medscape.com/viewarticle/821810. Accessed March 17, 2014.
Edwards KR, Norton J, Behnke M. Comparison of intravenous valproate versus intramuscular
dihydroergotamine and metoclopramide for acute treatment of migraine headache.
Headache. Nov-Dec 2001;41(10):976-80. [Medline].
Alstadhaug KB, Odeh F, Salvesen R, Bekkelund SI. Prophylaxis of migraine with melatonin: a
randomized controlled trial. Neurology. Oct 26 2010;75(17):1527-32. [Medline].
De Leo V, Scolaro V, Musacchio MC, Di Sabatino A, Morgante G, Cianci A. Combined oral
contraceptives in women with menstrual migraine without aura. Fertil Steril. Oct
2011;96(4):917-20. [Medline].
von Peter S, Ting W, Scrivani S, Korkin E, Okvat H, Gross M, et al. Survey on the use of
complementary and alternative medicine among patients with headache syndromes.
Cephalalgia. Jun 2002;22(5):395-400. [Medline].
Misra UK, Kalita J, Bhoi SK. Allodynia in Migraine: Clinical Observation and Role of
Prophylactic Therapy. Clin J Pain. Jan 16 2013;[Medline].
[Guideline] Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E.
Evidence-based guideline update: NSAIDs and other complementary treatments for
episodic migraine prevention in adults: report of the Quality Standards
Subcommittee of the American Academy of Neurology and the American Headache
Society. Neurology. Apr 24 2012;78(17):1346-53. [Medline]. [Full Text].
Krymchantowski AV, Jevoux C, Moreira PF. An open pilot study assessing the benefits
of quetiapine for the prevention of migraine refractory to the combination of
atenolol, nortriptyline, and flunarizine. Pain Med. Jan 2010;11(1):48-52. [Medline].
Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, et al. Topiramate
for migraine prevention: a randomized controlled trial. JAMA. Feb 25
2004;291(8):965-73. [Medline].
Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, et al. Efficacy of
gabapentin in migraine prophylaxis. Headache. Feb 2001;41(2):119-28. [Medline].
Jeffrey S. FDA Okays First Drug for Migraine Prevention in Adolescents. Medscape
Medical News [serial online]. Mar 28 2014;Accessed Apr 8 2014. Available at
http://www.medscape.com/viewarticle/822748.

More Related Content

Migraine